Browse drugs

…AR1302 (1mg/kg) was administered once per week for 3 weeks, and docetaxel (500µg) in 3 doses, every other day, for 1 week. Tumors, spleen…

… promoted tumour growth, with significant tumour restriction on atorvastatin pre-exposure. CCR7 low, CD40low, CD80 low, CD86 lowPDL1high FAS…

…ly developed a novel, chitosan-based injectable hydrogel called XCSgel. Prior work has shown that XCSgel is shear-thinning, self-heali…

…, liver, spleen or brain tissues at the 3mg/kg dose.Conclusions PB-vcMMAE-5 demonstrated potent in vitro and in vivo anti-tumor activity an…

…US-TBNA/TBNB with EUS-B-FNA/FNB does not seem to be superior to EBUS-TBNA/TBNB in terms of diagnostic accuracy in undiagnosed mediastinal…

…roup at exacerbation (D0) and first clinic visit (D7)Conclusion Prednisolone, unlike benralizumab had no effect on reducing eosinophil count…

…gue, or of switching to a different rapid-acting analogue or to faster aspart.Participants A total of 9695 and 2170 patients were included in…

…R will generate valuable prospective data on concomitant use of simoctocog alfa and emicizumab prophylaxis in patients with severe haemophilia …

… evidence that RLRL, 0.01% atropine, Ortho-k and 0.01% atropine+Ortho-k are all effective in suppressing myopia progress. In terms of l…

… propafenone and amiodarone, with no change seen in sotalol and dronedarone claims.Abstract 14 Figure 1…

…oral small molecule kinase inhibitors, such as upadacitinib and deucravacitinib, as potential additions to standard of care in SLE, considering…

…e estimated the comparative effect of incretin-based therapies (GLP-1RA and dipeptidyl-peptidase-4 inhibitors (DPP-4i)) versus sodium-g…